Neurocritical Management of Traumatic Acute Subdural Hematomas

Area of Science:

• Neurosurgery
• Traumatology
• Neurology

Background:

• Acute subdural hematoma (ASDH) is a significant complication of traumatic brain injury (TBI).
• ASDH can lead to intracranial hypertension, brain edema, and decreased cerebral blood flow (CBF).
• Primary brain injury severity is the most critical determinant of patient outcomes.

Purpose of the Study:

• To review current management strategies for acute subdural hematoma.
• To discuss the controversies and considerations in ASDH treatment.
• To highlight the importance of individualized patient care.

Main Methods:

• Literature review of ASDH pathophysiology and management.
• Analysis of treatment options including ICP lowering protocols, anti-epileptic drugs, anticoagulants, tranexamic acid, and surgical interventions.
• Discussion of surgical approaches like decompressive craniectomy and endoscopic surgery.

Main Results:

• The extent of primary brain injury is the key prognostic factor in ASDH.
• Controversies exist regarding the use of anti-epileptic drugs and anticoagulants/antiplatelets in ASDH patients.
• Tranexamic acid may reduce bleeding and mortality; decompressive craniectomy can lower death rates but carries surgical risks.

Conclusions:

• Management of ASDH requires careful consideration of patient-specific factors.
• Surgical interventions like decompressive craniectomy and endoscopic evacuation offer options to reduce mortality.
• Individualized treatment plans are essential for optimizing outcomes in acute subdural hematoma.